Trials / Completed
CompletedNCT00661284
A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)
A Study to Investigate the Duration of Maintained Efficacy in Patients With Rheumatoid Arthritis Who Had Treated With MRA
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 189 (actual)
- Sponsor
- Chugai Pharmaceutical · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
A 52-week follow up study to investigate the duration of maintenance of efficacy in patients with RA and achieved low disease activity in clinical trials of MRA and stopped the treatment
Conditions
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2009-03-01
- Completion
- 2010-05-01
- First posted
- 2008-04-18
- Last updated
- 2012-08-02
Locations
5 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00661284. Inclusion in this directory is not an endorsement.